| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |